Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study

Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study

Abstract Background Patients with interstitial lung disease (ILD) are at high risk of severe COVID-19 infection. Additionally, their anti-inflammatory and antifibrotic treatment may cause immunosuppression. Nevertheless, their ability to mount an adequate immune response to messenger RNA SARS-CoV-2...

Full description

Bibliographic Details
Main Authors: Barak Pertzov, Einat Shmueli, Haim Ben Zvi, Amir Massarweh, Tamar Barkan, Asaf Ness, Yael Shostak, Lev Freidkin, Osnat Shtraichman, Mordechai R. Kramer
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Respiratory Research
Online Access:https://doi.org/10.1186/s12931-022-02155-x

Internet

https://doi.org/10.1186/s12931-022-02155-x

Similar Items